TB meets COPD: An emerging global co-morbidity in human lung disease

Tuberculosis

Volumn 95, Issue 6, 2015, Pages 659-663

  O'Toole, Ronan F ^a   Shukla, Shakti D ^a   Walters, E Haydn ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Corticosteroid; Smoking; Tuberculosis

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CORTICOSTEROID THERAPY; DISEASE PREDISPOSITION; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; LUNG INFECTION; LUNG TUBERCULOSIS; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM KANSASII; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; DRUG EFFECTS; HOST PATHOGEN INTERACTION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; LUNG; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTIONS; PATHOGENICITY; PATHOPHYSIOLOGY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUBERCULOSIS, PULMONARY;

CORTICOSTEROID; TUBERCULOSTATIC AGENT;

ADRENAL CORTEX HORMONES; ANTITUBERCULAR AGENTS; COMORBIDITY; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNOCOMPROMISED HOST; LUNG; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTIONS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84948719912     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.08.005     Document Type: Review

References (53)

1. World Health Organisation Global tuberculosis report 2014
2. R.E. Chaisson, and N.A. Martinson Tuberculosis in Africa - combating an HIV-driven crisis N Engl J Med 358 2008 1089 1092
3. Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, Casazza JP, Ambrozak DR, Louder M, Ampofo W, Pollakis G, Hill B, Sanga E, Saathoff E, Maboko L, Roederer M, Paxton WA, Hoelscher M, Koup RA. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med;207:2869-81.
4. C. Geldmacher, A. Schuetz, N. Ngwenyama, J.P. Casazza, E. Sanga, E. Saathoff, C. Boehme, S. Geis, L. Maboko, M. Singh, F. Minja, A. Meyerhans, R.A. Koup, and M. Hoelscher Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection J Infect Dis 198 2008 1590 1598
5. J.H. Hwang, P.G. Choe, N.H. Kim, J.H. Bang, K.H. Song, W.B. Park, E.S. Kim, S.W. Park, H.B. Kim, N.J. Kim, M.D. Oh, and K.W. Choe Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection J Korean Med Sci 28 2013 374 377
6. S. Swaminathan, R. Ramachandran, G. Baskaran, C.N. Paramasivan, U. Ramanathan, P. Venkatesan, R. Prabhakar, and M. Datta Risk of development of tuberculosis in HIV-infected patients Int J Tuberc Lung Dis 4 2000 839 844
7. K.E. Dooley, and R.E. Chaisson Tuberculosis and diabetes mellitus: convergence of two epidemics Lancet Infect Dis 9 2009 737 746
8. T.C. Shen, C.L. Lin, C.C. Wei, W.C. Liao, W.C. Chen, C.H. Chen, C.Y. Tu, T.C. Hsia, C.M. Shih, W.H. Hsu, C.H. Li, and F.C. Sung Increased risk of tuberculosis in patients with type 1 diabetes mellitus: results from a population-based cohort study in Taiwan Med Baltim 93 2014 e96
9. The Lancet Diabetes E Diabetes and tuberculosis - a wake-up call Lancet Diabetes Endocrinol 2 2014 677
10. K. Lonnroth, B.G. Williams, S. Stadlin, E. Jaramillo, and C. Dye Alcohol use as a risk factor for tuberculosis - a systematic review BMC Public Health 8 2008 289
11. A. Fok, Y. Numata, M. Schulzer, and M.J. FitzGerald Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies Int J Tuberc Lung Dis 12 2008 480 492
12. M. Inghammar, A. Ekbom, G. Engstrom, B. Ljungberg, V. Romanus, C.G. Lofdahl, and A. Egesten COPD and the risk of tuberculosis - a population-based cohort study PLoS One 5 2010 e10138
13. A.L. Byrne, B.J. Marais, C.D. Mitnick, L. Lecca, and G.B. Marks Tuberculosis and chronic respiratory disease: a systematic review Int J Infect Dis 32 2015 138 146
14. WHO The top 10 causes of death Fact sheet No 310 2014
15. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med 3 2006 e442
16. A. Lokke, P. Lange, H. Scharling, P. Fabricius, and J. Vestbo Developing COPD: a 25 year follow up study of the general population Thorax 61 2006 935 939
17. B. Lundback, A. Lindberg, M. Lindstrom, E. Ronmark, A.C. Jonsson, E. Jonsson, L.G. Larsson, S. Andersson, T. Sandstrom, and K. Larsson Obstructive lung disease in Northern Sweden S. Not 15 but 50% of smokers develop COPD? - Report from the obstructive lung disease in Northern Sweden studies Respir Med 97 2003 115 122
18. M.D. Eisner, N. Anthonisen, D. Coultas, N. Kuenzli, R. Perez-Padilla, D. Postma, I. Romieu, E.K. Silverman, J.R. Balmes, Committee on Nonsmoking Copd E, and Occupational Health A An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease Am J Respir Crit Care Med 182 2010 693 718
19. M.N. Bates, A. Khalakdina, M. Pai, L. Chang, F. Lessa, and K.R. Smith Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis Arch Intern Med 167 2007 335 342
20. K. Slama, C.Y. Chiang, D.A. Enarson, K. Hassmiller, A. Fanning, P. Gupta, and C. Ray Tobacco and tuberculosis: a qualitative systematic review and meta-analysis Int J Tuberc Lung Dis 11 2007 1049 1061
21. H.H. Lin, M. Ezzati, and M. Murray Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis PLoS Med 4 2007 e20
22. S.M. O'Leary, M.M. Coleman, W.M. Chew, C. Morrow, A.M. McLaughlin, L.E. Gleeson, M.P. O'Sullivan, and J. Keane Cigarette smoking impairs human pulmonary immunity to Mycobacterium tuberculosis Am J Respir Crit Care Med 190 2014 1430 1436
23. S.S. Salvi, and P.J. Barnes Chronic obstructive pulmonary disease in non-smokers Lancet 374 2009 733 743
24. P. Narasimhan, J. Wood, C.R. Macintyre, and D. Mathai Risk factors for tuberculosis Pulm Med 2013 2013 828939
25. C.Y. Jeon, and M.B. Murray Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies PLoS Med 5 2008 e152
26. K. Lonnroth, G. Roglic, and A.D. Harries Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice Lancet Diabetes Endocrinol 2 2014 730 739
27. S. Glaser, S. Kruger, M. Merkel, P. Bramlage, and F.J. Herth Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature Respiration 89 2015 253 264
28. E.R. Turnbull, and F. Drobniewski Vitamin D supplementation: a comprehensive review on supplementation for tuberculosis prophylaxis Expert Rev Respir Med 2015 1 7
29. G.R. Zosky, L.J. Berry, J.G. Elliot, A.L. James, S. Gorman, and P.H. Hart Vitamin D deficiency causes deficits in lung function and alters lung structure Am J Respir Crit Care Med 183 2011 1336 1343
30. J.D. Finklea, R.E. Grossmann, and V. Tangpricha Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies Adv Nutr 2 2011 244 253
31. C.H. Lee, M.C. Lee, C.C. Shu, C.S. Lim, J.Y. Wang, L.N. Lee, and K.M. Chao Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study BMC Infect Dis 13 2013 194
32. C.C. Shu, H.D. Wu, M.C. Yu, J.T. Wang, C.H. Lee, H.C. Wang, J.Y. Wang, L.N. Lee, C.J. Yu, and P.C. Yang Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease Med Baltim 89 2010 53 61
33. S.S. Jick, E.S. Lieberman, M.U. Rahman, and H.K. Choi Glucocorticoid use, other associated factors, and the risk of tuberculosis Arthritis Rheum 55 2006 19 26
34. P. Brassard, S. Suissa, A. Kezouh, and P. Ernst Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases Am J Respir Crit Care Med 183 2011 675 678
35. C.H. Lee, K. Kim, M.K. Hyun, E.J. Jang, N.R. Lee, and J.J. Yim Use of inhaled corticosteroids and the risk of tuberculosis Thorax 68 2013 1105 1113
36. M. Hojo, M. Iikura, S. Hirano, H. Sugiyama, N. Kobayashi, and K. Kudo Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy Respirology 17 2012 185 190
37. C. Andrejak, R. Nielsen, V.O. Thomsen, P. Duhaut, H.T. Sorensen, and R.W. Thomsen Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis Thorax 68 2013 256 262
38. S. Ni, Z. Fu, J. Zhao, and H. Liu Inhaled corticosteroids (ICS) and risk of mycobacterium in patients with chronic respiratory diseases: a meta-analysis J Thorac Dis 6 2014 971 978
39. M. Inghammar, C.G. Lofdahl, N. Winqvist, B. Ljungberg, A. Egesten, and G. Engstrom Impaired pulmonary function and the risk of tuberculosis: a population-based cohort study Eur Respir J 37 2011 1285 1287
40. S. Sethi, and T.F. Murphy Infection in the pathogenesis and course of chronic obstructive pulmonary disease N Engl J Med 359 2008 2355 2365
41. T.S. Jordan, E.M. Spencer, and P. Davies Tuberculosis, bronchiectasis and chronic airflow obstruction Respirology 15 2010 623 628
42. A.F. Amaral, S. Coton, B. Kato, W.C. Tan, M. Studnicka, C. Janson, T. Gislason, D. Mannino, E.D. Bateman, S. Buist, P.G. Burney, and B.C.R. Group Tuberculosis associates with both airflow obstruction and low lung function: BOLD results Eur Respir J 2015 10.1183/13993003.02325-2014 http://erj.ersjournals.com/content/early/2015/06/24/13993003.02325-2014.long. PMID: 26113680. [in press]
43. P.A. Willcox, and A.D. Ferguson Chronic obstructive airways disease following treated pulmonary tuberculosis Respir Med 83 1989 195 198
44. M.L. Plit, R. Anderson, C.E. Van Rensburg, L. Page-Shipp, J.A. Blott, J.L. Fresen, and C. Feldman Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis Eur Respir J 12 1998 351 356
45. D. Gothi, D.V. Shah, and J.M. Joshi Clinical profile of diseases causing chronic airflow limitation in a tertiary care centre in India J Assoc Physicians India 55 2007 551 555
46. E. Hnizdo, T. Singh, and G. Churchyard Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment Thorax 55 2000 32 38
47. K. Dheda, H. Booth, J.F. Huggett, M.A. Johnson, A. Zumla, and G.A. Rook Lung remodeling in pulmonary tuberculosis J Infect Dis 192 2005 1201 1209
48. J.J. Yeh, Y.C. Wang, F.C. Sung, C.Y. Chou, and C.H. Kao Nontuberculosis mycobacterium disease is a risk factor for chronic obstructive pulmonary disease: a nationwide cohort study Lung 192 2014 403 411
49. C.T. Huang, Y.J. Tsai, H.D. Wu, J.Y. Wang, C.J. Yu, L.N. Lee, and P.C. Yang Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease Int J Tuberc Lung Dis 16 2012 539 545
50. R. Rodríguez-Roisin The airway pathophysiology of COPD: implications for treatment COPD J Chronic Obstr Pulm Dis 2 2005 253 262
51. A.E. Taylor, T.K. Finney-Hayward, J.K. Quint, C.M. Thomas, S.J. Tudhope, J.A. Wedzicha, P.J. Barnes, and L.E. Donnelly Defective macrophage phagocytosis of bacteria in COPD Eur Respir J 35 2010 1039 1047
52. C.S. Berenson, M.A. Garlipp, L.J. Grove, J. Maloney, and S. Sethi Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease J Infect Dis 194 2006 1375 1384
53. S. Shang, D. Ordway, M. Henao-Tamayo, X. Bai, R. Oberley-Deegan, C. Shanley, I.M. Orme, S. Case, M. Minor, D. Ackart, L. Hascall-Dove, A.R. Ovrutsky, P. Kandasamy, D.R. Voelker, C. Lambert, B.M. Freed, M.D. Iseman, R.J. Basaraba, and E.D. Chan Cigarette smoke increases susceptibility to tuberculosis - evidence from in vivo and in vitro models J Infect Dis 203 2011 1240 1248